跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Moscalair - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Moscalair
Approved
STANDARD
Moscalair
Sandoz Ilac Sanayi ve Ticaret A.Ş.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
426213d9af01e4f0
Company
Sandoz Ilac Sanayi ve Ticaret A.Ş.
Type
Standard
Approval Details
Approval Id
426213d9af01e4f0
Drug Approval Philippines Name
Moscalair
Product Name
Moscalair
Registration Number
DRP-5342
Brand Name
Moscalair
Generic Name
Montelukast (As Sodium)
Dosage Form
Chewable Tablet
Dosage Strength
4 mg
Manufacturer
Sandoz Ilac Sanayi ve Ticaret A.Ş.
Importer
Sandoz Philippines Corporation
Issuance Date
24 February 2023
Expiry Date
15 April 2028
Pharmacologic Category
Leukotriene Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
426213d9af01e4f0
Type
Standard
Back to Philippines FDA Approvals